A detailed history of Bruce G. Allen Investments, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 1,658 shares of GILD stock, worth $152,022. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,658
Previous 1,549 7.04%
Holding current value
$152,022
Previous $106 Million 30.8%
% of portfolio
0.11%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$66.59 - $83.99 $7,258 - $9,154
109 Added 7.04%
1,658 $139 Million
Q2 2024

Jul 12, 2024

BUY
$63.15 - $72.88 $505 - $583
8 Added 0.52%
1,549 $106 Million
Q1 2024

Apr 10, 2024

BUY
$71.58 - $87.29 $15,174 - $18,505
212 Added 15.95%
1,541 $113 Million
Q4 2023

Jan 10, 2024

BUY
$73.27 - $83.09 $97,375 - $110,426
1,329 New
1,329 $108 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.